Latest News & Updates

Breaking News

  • 3 hours ago

  • Beena Wood

Corporate Markets Manager
kedar-alt
FDA Quality Metrics Program Could Reshape Inspection Scheduling

Pharma Now Editorial Team

Other trending news you may like to read

Corporate Markets Manager

Caput arguo defendo.

Beena Wood

kedar-alt

FDA Quality Metrics Program Could Reshape Inspection Scheduling

FDA's Quality Metrics Reporting Program could reduce inspection frequency for facilities demonstrating sustainable compliance through objective manufacturing data.

Pharma Now Editorial Team

FDA Quality Metrics Program Could Reshape Inspection Scheduling

New NH Flu Strain Picks Signal Tight Manufacturing Window for 2026-2027

WHO's 2026–2027 flu strain picks are out. Vaccine plant heads and QA directors must act now on seed virus sourcing, process validation, and regulatory filings.

Pharma Now Editorial Team

New NH Flu Strain Picks Signal Tight Manufacturing Window for 2026-2027

PABS Annex Negotiations Advance — What It Means for Pharma Manufacturing

WHO Member States advanced PABS annex talks that could impose new manufacturing and technology-transfer obligations on pharma during future pandemics.

Pharma Now Editorial Team

PABS Annex Negotiations Advance — What It Means for Pharma Manufacturing